CLINICAL_TRIALS
trial_result
· 2021-04-19
Clinical Trial Update: A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease [Phase 1]
Summary
A Phase 1 study of LY3202626 in healthy participants and participants with Alzheimer's disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Healthy Volunteers, Alzheimer Disease | Phase 1 | Status: COMPLETED | Results posted: 2021-04-19